Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

NCT04101331

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles (UCLA) Health Los Angeles, California, United States
  • Emory University Clinic/Winship Cancer Institute Atlanta, Georgia, United States
View all 69 locations
View Trial Details
Completed

Study of Virtual Reality-based Medical Device for Patients with Depressive Disorder

NCT05701345

Conditions
Depressive Disorder, Depressive Disorder, Major, Depressive Episode, +13 more
Locations
  • Inje University Ilsan Palk Hospital Ilsan, South Korea
  • Jeju National University Hospital Jeju City, South Korea
  • Seoul ST. Mary's Hospital Seoul, South Korea
  • Yeouido ST. Mary's Hospital Seoul, South Korea
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

NCT02175433

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Site US0006 Duarte, California, United States
  • Site US0002 Stanford, California, United States
  • Site US0004 Fairway, Kansas, United States
  • Site US0001 New York, United States
View Trial Details
Completed

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma

NCT03846427

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Clinical Research Alliance, Inc Westbury, New York, United States
  • The Charlotte Mecklenburg Hospital Authority Charlotte, North Carolina, United States
  • Canberra Hospital Garran, Australian Capital Territory, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
View all 31 locations
View Trial Details
Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

NCT03493451

Conditions
ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
Locations
  • British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details
Completed

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

NCT03955783

Conditions
Acute Myeloid Leukemia, Diffuse Large B-cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Roswell Park Cancer Center Buffalo, New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details

Related conditions